BDUK Therapeutics LTD.
Yaron Suissa is a seasoned executive with extensive experience in the biotechnology and medical technology sectors. As the Chief Operations Officer and Co-Founder of BDUK Therapeutics LTD., Yaron is involved in developing a novel liver cancer therapy. Additionally, Yaron serves as a Management Consultant at YS MedTech Consulting, providing strategic support and financial planning in healthcare. Previous roles include Executive Advisor to the CEO at JLM-BioCity, EVP of R&D and Engineering at Olive Diagnostics, and CEO of OneCell Medical LTD. Yaron's entrepreneurial spirit is exemplified through the co-founding of JLM-BioCity, which fosters collaboration within the biomedical community. Educational credentials include a PhD in Life Science and an MBA in Financing and Strategy from The Hebrew University of Jerusalem.
This person is not in any teams
This person is not in any offices
BDUK Therapeutics LTD.
BDUK Therapeutics develops a groundbreaking liver cancer therapy, utilizing pre-existing drugs combined into a novel and highly potent therapeutic product for an orphan drug disease with optimal G2M strategy. The current Liver cancer market size is $11 Bn, with no effective therapy (20% 5yr survival rate). The technology was developed in the Hebrew University and received the prestigious European Research Council (ERC) grant.